SAM
MMSI icon

Silvercrest Asset Management’s Merit Medical Systems MMSI Stock Holding History

Silvercrest Asset Management’s Portfolio MMSI Stock Details MMSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Sell
239,197
-20,458
-8% -$1.35M 0.11% 249
2026
Q1 		$17.9M Buy
259,655
+55,639
+27% +$4.35M 0.13% 209
2025
Q4 		$18M Buy
+204,016
New +$17.4M 0.12% 226

Other funds holding MMSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Silvercrest Asset Management's MMSI Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Merit Medical Systems (MMSI) stake by 7.9% in Q2 2026, selling an estimated $1.35M and leaving 239,197 shares worth $16.6M. The position accounts for 0.11% of the portfolio, ranked #249.

Silvercrest Asset Management first reported a position in MMSI in Q4 2025 and has held it in 3 quarters since. The position peaked at $18M in Q4 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Silvercrest Asset Management held 239,197 shares of Merit Medical Systems worth $16.6M as of Q2 2026.
  • Silvercrest Asset Management sold 20,458 Merit Medical Systems shares in Q2 2026, an estimated $1.35M.
  • Merit Medical Systems made up 0.11% of Silvercrest Asset Management's portfolio in Q2 2026, its #249 holding.
  • Silvercrest Asset Management first reported a position in Merit Medical Systems in Q4 2025 and has held it in 3 quarters since.
  • Silvercrest Asset Management's Merit Medical Systems position peaked at $18M in Q4 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.